Expression of complement inhibitors CD46, CD55, and CD59 on tumor cells does not predict clinical outcome after rituximab treatment in follicular non-Hodgkin lymphoma

Search this article

Journal

  • Blood

    Blood 98 1352-1357, 2001

Citations (4)*help

See more

Details 詳細情報について

Report a problem

Back to top